Table 4 Immunohistochemical characteristics of ML at MNH
From: Malignant lymphomas (ML) and HIV infection in Tanzania
| Â | IMMUNOREACTIVITY FOR: | ||||
|---|---|---|---|---|---|
TUMOUR | LCA* | CD20 | CD3 | CD68 | MEAN Ki-67 (% +/HPF) |
BL | Reactive (membranous cytoplasmic) in all tumour and infiltrating cells | Reactive (membranous cytoplasmic) in all tumour cells | Focal (membranous cytoplasmic) reactivity in infiltrating T-cells | Focal (membranous cytoplasmic) reactivity in infiltrating phagocytes | 70.0 |
NHL | Reactive (membranous cytoplasmic) in all tumour and infiltrating cells | Reactive (membranous cytoplasmic) in all tumour cells | Focal (membranous cytoplasmic) reactivity in infiltrating T-cells | Focal (membranous cytoplasmic) reactivity in infiltrating phagocytes | 40.0 |
HD | Reactive (membranous cytoplasmic) in all tumour and infiltrating cells | Focal reactivity in infiltrating B-cells while RS and Hodgkin cells negative | Focal reactivity in infiltrating T-cells | Focal (membranous cytoplasmic) reactivity in infiltrating phagocytes | 25.0 |